Share Twitter LinkedIn Facebook Email Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Few Therapeutic MDS Options for Patients Incorporating novel agents on trials in the right time at Imedex Great Debates 2018.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read